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Abstract: Primary Cranial Ewing sarcoma (ES) is rare and that of temporal bone is even 
rarer entity. Only a few sporadic cases have been reported and no such case has been 
reported from Eastern India  
In this report we describe a case of 18 yrs old male with primary cranial ES of squamous 
temporal bone involving intracranial and extracranial compartment. The patient 
presented with swelling in zygomatic fossa and imaging studies showed a mass 
originating in the right temporal bone. Gross total resection of the tumor was done and 
sent for histopathological study. The case was referred for radio-chemotherapy and had 
no recurrence up to eight months of follow up. 
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Introduction 
Ewing sarcoma (ES), also called peripheral 
primitive neuroectodermal tumor (PNET) 
commonly originates from bone and soft 
tissue of extremities and pelvis [1]. The skull is 
involved in less than two percent of cases [2,3]. 
Till now only 14 such cases involving temporal 
bone have been reported in the literature .One 
such case is being reported. 
Case History 
A 18 year old male child presented with 
history of swelling in his right temporal region 
since one year. The swelling was increasing in 
size and associated with pain since last one 
month. There was no preceding history of 
trauma and fever. Physical examination 
suggested a palpable mass in right temporal 
region of 8 x 6 cm in size. The mass was firm 
and fixed to underlying bone. Overlying skin 
was free and distended veins were seen over 
the swelling (Figure 1). His general as well as 
systemic examination and neurological status 
was within normal limits. 
His routine haematological and 
biochemical investigations were normal. 
Ultrasonographic evaluation of abdomen and 
thorax were normal.  Skeletal radiographs 
revealed no other extracranial lesion. CT scan 
of brain showed increased attenuating 
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enhancing lesion in right temporal area with 
involvement of inner and outer table of right 
squamous temporal bone with both intra and 
extracranial extension. MRI study of Brain 
revealed extra-axial mass in right temporal 
region with involvement of bone and 
extracalvarial soft tissue swelling showing 
marked enhancement on contrast study 
(Figure 2). 
Plan for excision of mass was decided. A 
Right Fronto-Temporo-Parietal craniotomy 
was performed. Intraoperatively a firm tumor 
was noted which originated from the 
squamous part of temporal bone, extending 
extradurally under temporal lobe and involved 
dura. Gross total excision of tumor and 
involved dura was done and sent for 
histopathological study. 
Hematoxylin & Eosin (H&E) stained 
sections revealed tumor mass composed of 
uniform small round cells with round nuclei 
containing fine chromatin, scanty cytoplasm 
and indistinct cytoplasmic membrane. 
Immunohistochemistry for CD 99 was 
positive and negative for GFAP and vimentin 
(Figure 3). Histopathological diagnosis was 
Ewing sarcoma.  
The patient subsequently received 
induction chemotherapy with 
cyclophosphamide, vincristine and 
adriamycin alternating with ifophospamide 
and etoposide administered at 3 weeks. The 
local area was irradiated with 40–50 Gy eight 
weeks later. This was followed by eight cycles 
of chemotherapy same as induction at 3-week 
intervals. Patient was followed for eight 
months after radiochemotherapy where he 
developed no recurrence and later lost in 
follow up. 
 
Figure 1 - Preoperative -Right temporal palpable 
swelling extending to frontal and parietal region 
 
 
Figure 2 - Axial contrast enhanced CT images show 
enhancing lesion in right temporal region with 
involvement of right squamous temporal bone and 
overlying scalp tissue 
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Figure 3 - T2W coronal and TIW axial contrast MRI 
image reveals well defined extra-parenchymal and 
extra calvarial lesion maintaining distinct border with 
brain and shows marked contrast enhancement 
 
 
Figure 4 - a. Tumor section showing small round 
cells (H&E, x400).  b. Tumor cells showing strong 
membranous staining for CD99 (immunoperoxidase, 
x400) 
Discussion 
ES is a highly malignant bone tumor arising 
from the pleuripotent cells in bone marrow or 
primordial bone marrow derived mesenchymal 
stem cells [4,5]. The tumor is now classified 
under Ewing Sarcoma Family of Tumor (ESFT) 
which includes Classic Ewing sarcoma, PNET, 
Askin tumor and Extra osseous Ewing sarcoma 
[6]. Median age of patient with ESFT is 15 years 
and more than 50% are adolescent. The Tumor 
primarily involves lower extremity (41%), 
pelvis (26%), chest wall (16%) & upper 
extremity (9%) [7]. Common presentations are 
localised bone pain and swelling, local 
tenderness, palpable mass. 
 In the present case, the presenting 
symptom was a large swelling in the temporal 
region with no evidence of symptoms of 
elevated intracranial pressure suggesting 
extracranial extension was larger part of 
tumor. The predominant presenting feature in 
other such reported cases was scalp swelling, 
headache and findings of raised intracranial 
pressure. 
Involvement of cranium by ES is very rare. 
Only 29 cases of primary ES of cranium have 
been reported [8] and 14 cases pertaining to 
involvement of temporal bone.  
CT of Ewing's sarcoma has often shown a 
diffusely enhancing hyperdense extra axial 
mass and extensive bone destruction involving 
both inner and outer table. The present case 
also had similar findings on the CT scan of 
brain [2,9,10,11].  
Differential diagnosis of such large and 
progressively increasing mass can be 
embryonal rhabdomyaosarcoma, lymphoma 
or metastatic neuroblastoma. ES as diagnosis 
was confirmed by CD 99 positivity.  
Management of such tumor is radical 
excision and radio-chemotherapy [12]. 
Current standard chemotherapy includes 
vincristine, doxorubicin and 
cyclophosphamide alternating with ifosfamide 
and etoposide [13,14].   
The prognosis for patient with ES has 
improved considerably with current treatment 
protocol. However outcome for patient with 
metastasis or early relapse is poor. 
Though primary cranial ES of temporal 
bone is rare, it should be kept as differential 
diagnosis in cases of temporal scalp swelling. 
The present case is exceptional as it originates 
from the squamous part of temporal bone and 
no such tumor has been described from 
eastern India. 
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